HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Régis Costello Selected Research
Régis Costello Research Topics
Disease
5
Neoplasms (Cancer)
04/2022 - 07/2010
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2021 - 11/2015
3
Multiple Myeloma
01/2018 - 01/2002
2
Leukemia
04/2022 - 06/2021
2
Lymphoma (Lymphomas)
01/2018 - 07/2010
1
Death (Near-Death Experience)
04/2022
1
Plasmablastic Lymphoma
04/2021
1
Frailty
12/2020
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020
1
Fatigue
01/2020
1
Hematologic Neoplasms (Hematological Malignancy)
01/2018
1
Sepsis (Septicemia)
01/2018
1
Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2018
1
Hodgkin Disease (Hodgkin's Disease)
11/2015
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2015
1
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
11/2015
1
HIV Infections (HIV Infection)
11/2015
1
Hematoma
03/2014
1
Amyloidosis
03/2014
1
Venous Thromboembolism
10/2013
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
07/2010
1
T-Cell Lymphoma (Lymphoma, T Cell)
07/2010
1
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
07/2010
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
07/2010
1
Lysosomal Storage Diseases (Lysosomal Storage Disease)
07/2006
1
Cytopenia
07/2006
1
Gaucher Disease (Gaucher's Disease)
07/2006
1
Discitis
01/2002
Drug/Important Bio-Agent (IBA)
2
Cytarabine (Cytosar-U)
FDA Link
Generic
06/2021 - 09/2019
1
Anthracyclines
IBA
06/2021
1
daratumumab
IBA
04/2021
1
Vitamin B 12 (Cyanocobalamin)
FDA Link
Generic
12/2020
1
Biomarkers (Surrogate Marker)
IBA
12/2020
1
2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- one
IBA
12/2020
1
C-Reactive Protein
IBA
12/2020
1
Lenalidomide (CC 5013)
FDA Link
01/2020
1
purine
IBA
09/2019
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2018
1
Cytidine Deaminase
IBA
11/2015
1
Azacitidine (5 Azacytidine)
FDA Link
11/2015
1
Muramidase (Lysozyme)
IBA
03/2014
1
Immunomodulating Agents
IBA
10/2013
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
07/2010
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
07/2010
1
NF-kappa B (NF-kB)
IBA
07/2010
1
Interferon-alpha (Interferon Alfa)
IBA
07/2010
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2010
1
Glucosylceramidase (Glucocerebrosidase)
IBA
07/2006
1
Glucosylceramides (Glucocerebrosides)
IBA
07/2006
1
Immunoglobulin A (IgA)
IBA
01/2002
Therapy/Procedure
3
Therapeutics
06/2021 - 11/2015
2
Drug Therapy (Chemotherapy)
04/2022 - 01/2002
1
Terminal Care (Care, Terminal)
04/2022
1
Gastrostomy
04/2022
1
Length of Stay
04/2022
1
Renal Dialysis (Hemodialysis)
04/2022
1
Nutritional Support (Artificial Feeding)
04/2022
1
Cardiopulmonary Resuscitation (CPR)
04/2022
1
Palliative Care (Palliative Therapy)
04/2022
1
Artificial Respiration (Mechanical Ventilation)
04/2022
1
Activities of Daily Living (ADL)
01/2022
1
Immunotherapy
06/2021
1
Ambulatory Care (Outpatient Care)
12/2020
1
Induction Chemotherapy
01/2020
1
Hematopoietic Stem Cell Transplantation
01/2018
1
Conservative Treatment
03/2014